Form 8-K - Current report:
SEC Accession No. 0000950103-23-005621
Filing Date
2023-04-12
Accepted
2023-04-12 07:35:04
Documents
14
Period of Report
2023-04-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp192149_8k.htm   iXBRL 8-K 33451
2 EXHIBIT 99.1 dp192149_ex9901.htm EX-99.1 16273
3 GRAPHIC image_012.jpg GRAPHIC 3563
  Complete submission text file 0000950103-23-005621.txt   234847

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE blco-20230410.xsd EX-101.SCH 3221
5 XBRL LABEL FILE blco-20230410_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE blco-20230410_pre.xml EX-101.PRE 22355
8 EXTRACTED XBRL INSTANCE DOCUMENT dp192149_8k_htm.xml XML 3580
Mailing Address 520 APPLEWOOD CRESCENT VAUGHAN A6 L4K 4B4
Business Address 520 APPLEWOOD CRESCENT VAUGHAN A6 L4K 4B4 908-541-5456
Bausch & Lomb Corp (Filer) CIK: 0001860742 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41380 | Film No.: 23814635
SIC: 3851 Ophthalmic Goods